Behind Gobia Enterprises stands a dedicated team with extensive experience in investments, business development, and international growth. Their commitment and expertise drive Gobia’s vision and continued success.
Chairman of the Board
Jan has over 40 years of experience in leading and building international companies in pharmaceuticals and medical technology. Founder of ABIGO Medical, with sales in 65 countries and strong internationally patented and well-known brands. Jan holds a degree from Sir George William University.
Partner
Jan Erik has previously worked in international roles at the medical technology company Getinge Group and ABIGO Medical. He currently works as Vice President at Circius Pharma. He also represents Gobia Enterprises on the board of several of the portfolio companies. Jan Erik holds a Master of Science degree in Business Administration from Lund University.
CFO
Johan has a long experience as CFO within medical technology at ABIGO Medical and Essity. He has also previously worked as an accountant at E&Y. Johan is currently serving as CFO at Gobia Enterprises and Circius Pharma. Johan holds an MBA from Gothenburg University.
CCO & Advisor
Erik has a background from AstraZeneca, Novartis and Mölnlycke Healthcare within sales, marketing and business development. Erik is advisor at Gobia Enterprises and also Chief Commercial Officer at Circius Pharma. Erik holds a Master of Science in Business Administration from Gothenburg University. Erik serves on the board of directors of Dx4Life.
Our goal is to create a globally successful company. We will do this through long-term collaborations, innovative products and a large portion of entrepreneurship and forward thinking!
Jan G Smith
Chairman of the Board
CEO Circius Pharma
Want to get in touch with us?
Contact usWe invest in companies and ideas with clear potential for development and growth. Our primary focus is on companies where our experience can have significant impact, innovations with international potential. However, we remain open to opportunities with more established companies when the right conditions align.